Sun, Peng
Li, Zhenfeng
Yan, Zaojun
Wang, Zhaofeng
Zheng, Peng
Wang, Mingliang
Chang, Xu
Liu, Zihao
Zhang, Jianxin
Wu, Huiyong
Shao, Wenbo
Xue, Dewen
Yu, Jinming
Funding for this research was provided by:
Shandong Provincial Natural Science Foundation (ZR2023QH127, ZR2020QH177, ZR2023QH127, ZR2020QH177)
Academic Promotion Program of Shandong First Medical University (2019ZL002)
Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences (2019RU071)
the foundation of National Natural Science Foundation of China (81627901, 81972863 and 82030082)
the foundation of Natural Science Foundation of Shandong (ZR201911040452)
Article History
Received: 14 November 2023
Accepted: 23 July 2024
First Online: 30 July 2024
Declarations
:
: This research was approved by the Medical Ethics Committee of Shandong Cancer Hospital and Institute (SDTHEC2022007011). And the informed consent was obtained from all HCC patients. Animal experimental protocols were approved by the Animal Ethics Committee of Shandong Cancer Hospital and Institute (SDTHEC202201044). All methods involving animals were reported in accordance with ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.
: The authors affirm that human research participants provided informed consent for publication of the images in Fig. 1A and B C.
: The authors declare no competing interests.